Inozyme Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2017 - 2021
Period Ending	Aug '25 Aug 7, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2017 - 2021
Market Capitalization	877,500	731,900	-	-	-	-	Upgrade
Enterprise Value	940,396	810,541	-	-	-	-	Upgrade
Last Close Price	1757.20	1449.42	-	-	-	-	Upgrade
PE Ratio	63.86	49.00	-	-	-	-	Upgrade
PS Ratio	9.86	8.56	-	-	-	-	Upgrade
PB Ratio	13.88	12.34	-	-	-	-	Upgrade
P/FCF Ratio	26.35	23.51	-	-	-	-	Upgrade
P/OCF Ratio	19.00	15.97	-	-	-	-	Upgrade
EV/Sales Ratio	10.57	9.48	-	-	-	-	Upgrade
EV/EBITDA Ratio	20.24	20.63	-	-	-	-	Upgrade
EV/EBIT Ratio	37.30	35.86	-	-	-	-	Upgrade
EV/FCF Ratio	28.24	26.04	-	-	-	-	Upgrade
Debt / Equity Ratio	1.02	1.24	1.75	2.19	2.48	3.91	Upgrade
Debt / EBITDA Ratio	1.38	1.69	2.32	3.19	4.78	6.84	Upgrade
Debt / FCF Ratio	1.93	2.36	5.45	2.21	-	128.91	Upgrade
Asset Turnover	0.48	0.45	0.39	0.38	0.34	0.30	Upgrade
Quick Ratio	0.04	0.10	0.16	0.29	0.48	0.15	Upgrade
Current Ratio	0.29	0.28	0.32	0.47	0.65	0.27	Upgrade
Return on Equity (ROE)	23.95%	28.26%	11.40%	13.96%	59.31%	-41.31%	Upgrade
Return on Assets (ROA)	8.51%	7.48%	5.95%	4.78%	1.80%	-0.61%	Upgrade
Return on Capital (ROIC)	12.38%	10.85%	8.36%	6.38%	2.54%	-0.94%	Upgrade
Return on Capital Employed (ROCE)	19.80%	18.20%	15.90%	11.00%	4.40%	-	Upgrade
Earnings Yield	1.57%	2.04%	-	-	-	-	Upgrade
FCF Yield	3.79%	4.25%	-	-	-	-	Upgrade
Dividend Yield	0.57%	0.69%	-	-	-	-	Upgrade
Payout Ratio	14.56%	13.39%	14.87%	-	-	-	Upgrade
Total Shareholder Return	0.54%	0.69%	-	-	-	-	Upgrade

Updated Feb 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.